Brooke E. Shaner

961 total citations
8 papers, 260 citations indexed

About

Brooke E. Shaner is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Brooke E. Shaner has authored 8 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Nephrology and 2 papers in Surgery. Recurrent topics in Brooke E. Shaner's work include Pain Mechanisms and Treatments (2 papers), Receptor Mechanisms and Signaling (2 papers) and Neuropeptides and Animal Physiology (2 papers). Brooke E. Shaner is often cited by papers focused on Pain Mechanisms and Treatments (2 papers), Receptor Mechanisms and Signaling (2 papers) and Neuropeptides and Animal Physiology (2 papers). Brooke E. Shaner collaborates with scholars based in United States, France and China. Brooke E. Shaner's co-authors include Midhun C. Korrapati, Rick G. Schnellmann, Francis M. Hughes, Justin O. Brower, Thomas A. Dix, Danielle W. Lowe, Paul J. Nietert, J. Todd Purves, R. Jeremy Woods and Laura Spruill and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and The Journal of Urology.

In The Last Decade

Brooke E. Shaner

8 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brooke E. Shaner United States 7 131 51 47 35 34 8 260
A.V. Kazachenko Russia 6 92 0.7× 61 1.2× 13 0.3× 7 0.2× 61 1.8× 18 243
Chen Xia China 9 103 0.8× 22 0.4× 11 0.2× 6 0.2× 78 2.3× 23 328
Nikola Radović Serbia 9 162 1.2× 143 2.8× 6 0.1× 10 0.3× 45 1.3× 16 404
Courtney Shea United States 7 90 0.7× 145 2.8× 21 0.4× 6 0.2× 12 0.4× 16 443
G. Taton Belgium 12 234 1.8× 115 2.3× 182 3.9× 24 0.7× 23 0.7× 22 581
Midori Okamura Japan 11 114 0.9× 32 0.6× 23 0.5× 2 0.1× 39 1.1× 13 336
Sung L. Hsia United States 9 106 0.8× 47 0.9× 5 0.1× 33 0.9× 33 1.0× 16 376
MA Xiu-mei China 6 95 0.7× 25 0.5× 9 0.2× 4 0.1× 7 0.2× 10 265

Countries citing papers authored by Brooke E. Shaner

Since Specialization
Citations

This map shows the geographic impact of Brooke E. Shaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brooke E. Shaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brooke E. Shaner more than expected).

Fields of papers citing papers by Brooke E. Shaner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brooke E. Shaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brooke E. Shaner. The network helps show where Brooke E. Shaner may publish in the future.

Co-authorship network of co-authors of Brooke E. Shaner

This figure shows the co-authorship network connecting the top 25 collaborators of Brooke E. Shaner. A scholar is included among the top collaborators of Brooke E. Shaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brooke E. Shaner. Brooke E. Shaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Qanungo, Suparna, Joachim D. Uys, Yefim Manevich, et al.. (2014). N-acetyl-l-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway. Biomedicine & Pharmacotherapy. 68(7). 855–864. 24 indexed citations
2.
Lowe, Danielle W., et al.. (2014). MP8-15 INFLAMMASOMES ARE IMPORTANT MEDIATORS OF CYCLOPHOSPHAMIDE-INDUCED BLADDER INFLAMMATION. The Journal of Urology. 191(4S). 1 indexed citations
3.
Hughes, Francis M., Brooke E. Shaner, Justin O. Brower, R. Jeremy Woods, & Thomas A. Dix. (2013). Development of a Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonist Targeting Peripheral Pain. PubMed. 7(1). 16–22. 26 indexed citations
4.
Korrapati, Midhun C., et al.. (2013). Suramin: A Potential Therapy for Diabetic Nephropathy. PLoS ONE. 8(9). e73655–e73655. 17 indexed citations
5.
Hughes, Francis M., Danielle W. Lowe, Brooke E. Shaner, et al.. (2013). Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation. American Journal of Physiology-Renal Physiology. 306(3). F299–F308. 70 indexed citations
6.
Korrapati, Midhun C., Brooke E. Shaner, Benjamin A. Neely, et al.. (2012). Diabetes-Induced Renal Injury in Rats Is Attenuated by Suramin. Journal of Pharmacology and Experimental Therapeutics. 343(1). 34–43. 25 indexed citations
7.
Korrapati, Midhun C., Brooke E. Shaner, & Rick G. Schnellmann. (2012). Recovery from Glycerol-Induced Acute Kidney Injury Is Accelerated by Suramin. Journal of Pharmacology and Experimental Therapeutics. 341(1). 126–136. 70 indexed citations
8.
Hughes, Francis M., Brooke E. Shaner, Lisa May, et al.. (2010). Identification and Functional Characterization of a Stable, Centrally Active Derivative of the Neurotensin (8−13) Fragment as a Potential First-in-Class Analgesic. Journal of Medicinal Chemistry. 53(12). 4623–4632. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026